Topic
Tom Bilyeu
Peter Attia and Tom Bilyeu discuss a concerning trend in modern society where life expectancy for men aged 30 to 60 has plateaued or declined due to what Attia terms "deaths of despair," primarily driven by suicide, overdoses, and opioid misuse. While advancements like antibiotics have historically …
Chris Williamson
Dr. Mike Israetel addresses the efficacy of supplements for fat loss, distinguishing between modern anorectics and traditional stimulants like caffeine or Yim E beans. While he acknowledges that certain appetite suppressants can offer marginal benefits regarding mental clarity and hunger reduction w …
Chris Williamson
In this end-of-year recap, the host synthesizes key lessons from 2024, focusing primarily on dismantling the mindset of the insecure overachiever who equates worry with performance enhancement and views success as a minimum requirement rather than cause for celebration. Drawing on insights from Andr …
The Diary Of A CEO
Dr. Tina Moore, a naturopathic physician and chiropractor, challenges mainstream narratives regarding Ozempic (semaglutide), arguing that while high doses prescribed for rapid weight loss carry significant risks of side effects like pancreatitis and gallstones, microdosing the drug offers profound t …
Andrew Huberman
Dr. Peter Attia joins Andrew Huberman to discuss a comprehensive framework for optimizing health span and lifespan, emphasizing that longevity is driven by two primary vectors: preventing death from major diseases (lifespan) and maintaining functional vitality (health span). Regarding blood work as …
Andrew Huberman
Dr. Zachary Knight, a Howard Hughes Medical Institute investigator and professor at UCSF, explains that food intake regulation relies on two distinct neural systems operating on different time scales: short-term circuits in the brainstem controlling meal size over minutes to hours, and long-term cir …
Andrew Huberman
In this episode of the Huberman Lab podcast, host Andrew Huberman interviews Dr. Craig Conover, a medical doctor and expert in performance medicine who specializes in peptide therapies for health, longevity, and cognitive function. The discussion centers on peptides as small chains of amino acids th …
Andrew Huberman
In this episode of the Huberman Lab podcast, host Andrew Huberman interviews Ryan Soave, a renowned expert in addiction treatment and trauma recovery who serves as Chief Clinical Officer for Guardian Recovery. The discussion begins by reframing the concept of addiction not merely as a disease but of …
Andrew Huberman
Modern "trinity stacks" combining GLP-1 agonists like Ozempic or Mounjaro with growth hormone secretagogues such as Tesamorelin and MK677 have gained popularity among celebrities for rapid body transformation, yet their long-term safety remains unproven. Peptides are broadly categorized into those t …